BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10376443)

  • 1. Correlates of long-term hypocortisolism after transsphenoidal microsurgery for Cushing's disease.
    Flitsch J; Lüdecke DK; Knappe UJ; Saeger W
    Exp Clin Endocrinol Diabetes; 1999; 107(3):183-9. PubMed ID: 10376443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
    Flitsch J; Knappe UJ; Lüdecke DK
    Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra- and postoperative plasma ACTH concentrations in patients with Cushing's disease cured by transsphenoidal pituitary surgery.
    Czirják S; Bezzegh A; Gál A; Rácz K
    Acta Neurochir (Wien); 2002 Oct; 144(10):971-7; discussion 977. PubMed ID: 12382124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of recovery of adrenocortical function after treatment for Cushing's syndrome due to pituitary or adrenal adenomas.
    Klose M; Jørgensen K; Kristensen LØ
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):394-9. PubMed ID: 15355458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
    Imaki T; Tsushima T; Hizuka N; Odagiri E; Murata Y; Suda T; Takano K
    Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.
    Oldfield EH; Vance ML; Louis RG; Pledger CL; Jane JA; Lopes MB
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of Cushing's syndrome by selective excision of pituitary adenoma. 3 cases (author's transl)].
    Riviere J; Manciet G; Roger P; Guerin J; Barraud AM; Mauriac L; Kern AM; Rashedi M
    Nouv Presse Med; 1979 Jun; 8(27):2255-9. PubMed ID: 226930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cushing's disease resulting from pituitary corticotrophic microadenoma. Treatment results from transsphenoidal microsurgery and gamma knife radiosurgery.
    Laws ER; Reitmeyer M; Thapar K; Vance ML
    Neurochirurgie; 2002 May; 48(2-3 Pt 2):294-9. PubMed ID: 12058134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: prediction of outcome.
    Arnott RD; Pestell RG; McKelvie PA; Henderson JK; McNeill PM; Alford FP
    Acta Endocrinol (Copenh); 1990 Oct; 123(4):423-30. PubMed ID: 2173325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission of pituitary-dependent Cushing's disease after removal of nonneoplastyic pituitary gland.
    Taylor HC; Velasco ME; Brodkey JS
    Arch Intern Med; 1980 Oct; 140(10):1366-8. PubMed ID: 6252859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRH test after pituitary microsurgery suggests tertiary adrenocortical insufficiency in successful operated patients with Cushing's disease.
    Schrell U; Fahlbusch R; Buchfelder M; Riedl S; Stalla GK; Müller OA
    Horm Metab Res Suppl; 1987; 16():64-5. PubMed ID: 2832294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINAC radiosurgery in recurrent Cushing's disease after transsphenoidal surgery: a series of 5 cases.
    Wong GK; Leung CH; Chiu KW; Ma R; Cockram CS; Lam MJ; Poon WS
    Minim Invasive Neurosurg; 2003 Dec; 46(6):327-30. PubMed ID: 14968397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary pathology in Cushing's disease. Histology and morphometry of pituitary tissues removed through microsurgery.
    Olivier L; Vila-Porcile E
    Pathol Res Pract; 1988 Sep; 183(5):587-91. PubMed ID: 3237548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical pathology of the pituitary in Cushing's disease.
    Saeger W
    Pathol Res Pract; 1991 Jun; 187(5):613-6. PubMed ID: 1656411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.
    Bakiri F; Tatai S; Aouali R; Semrouni M; Derome P; Chitour F; Benmiloud M
    J Endocrinol Invest; 1996 Oct; 19(9):572-80. PubMed ID: 8957739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct intraoperative micromethod for hormone measurements of pituitary tissue in Cushing's disease.
    Flitsch J; Knappe UJ; Lüdecke DK
    Surg Neurol; 1999 Dec; 52(6):585-90; discussion 590-1. PubMed ID: 10660024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cushing's disease: management by transsphenoidal pituitary microsurgery.
    Bigos ST; Somma M; Rasio E; Eastman RC; Lanthier A; Johnston HH; Hardy J
    J Clin Endocrinol Metab; 1980 Feb; 50(2):348-54. PubMed ID: 7354119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.